Daxor Corporation (DXR)

Panoramica Notizia Cronologia dei prezzi Forum Previsione Storia dei dividendi

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Daxor Corporation Stock (DXR) Company Profile

Daxor Corporation

Healthcare (1116)

212-330-8500

Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY

Prossima data di guadagno

Ultimi documenti SEC

DXR's Discussions on Twitter

Compare DXR vs ISRG, BDX, ALC, MDLN, RMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
DXR Daxor Corporation	11.48	66.90M	503.40K	9.17M	-604.40K	1.8109
ISRG Intuitive Surgical Inc	472.16	167.68B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	159.36	45.33B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	77.32	37.69B	10.40B	980.00M	1.61B	1.9749
MDLN Medline Inc	41.46	33.65B	28.43B	1.16B	1.26B	1.4457
RMD Resmed Inc	230.84	33.63B	5.40B	1.49B	1.78B	10.12

Daxor Corporation Stock (DXR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2019-05-16	Iniziato	Ascendiant Capital Markets	Buy

Daxor Corporation Borsa (DXR) Ultime notizie

Daxor Corporation Azioni (DXR) Dati Finanziari

Daxor Corporation (DXR)

Daxor Corporation Stock (DXR) Company Profile

Compare DXR vs ISRG, BDX, ALC, MDLN, RMD

Daxor Corporation Stock (DXR) Upgrades & Downgrades

Daxor Corporation Borsa (DXR) Ultime notizie

DXR: Direct blood volume analysis drives improved outcomes and rapid revenue growth in a vast market - TradingView

Daxor (DXR) Unveils Portable Blood Volume Analyzer at Critical C - GuruFocus

Daxor Corporation Showcases New Portable Blood Volume Analyzer - marketscreener.com

Daxor to debut portable blood volume analyzer at SCCM Critical Care Congress - TipRanks

Daxor to Debut New Rapid, Portable Blood Volume Analyzer at SCCM 2026 Critical Care Congress - GlobeNewswire

Daxor Corporation to Participate in the iAccess Virtual Alpha Best Ideas Spring Investment Conference 2026 - GlobeNewswire

Market Overview: Will Murano Global Investments Plc Equity Warrant benefit from rate cuts2026 Top Gainers & Free Growth Oriented Trading Recommendations - baoquankhu1.vn

What analyst consensus says on Daxor Corporation stockExit Point & Fast Moving Trade Plans - Naître et grandir

Layoff Watch: Is Daxor Corporation a turnaround storyGap Up & Safe Entry Trade Reports - baoquankhu1.vn

Daxor (NYSEAMERICAN:DXR) Share Price Passes Below 200-Day Moving AverageHere's What Happened - MarketBeat

European Stocks Set for Mixed Opening Amid Geopolitical Tensions - Intellectia AI

DXR SEC FilingsDAXOR CORP 10-K, 10-Q, 8-K Forms - Stock Titan

Daxor Corporation Reports 2025 Fiscal Year Results, Operating Revenue Up 45%, Net Asset Value Rises to $9.07 per Share - marketscreener.com

Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders - Bitget

Daxor reports 45% revenue growth, plans regulatory shift - Investing.com

Daxor Corporation CEO and President Michael Feldschuh provides corporate update in letter to shareholders - marketscreener.com

Daxor (DXR) Records Strong Growth and Regulatory Changes in 2025 - GuruFocus

Daxor issues update in Letter to Shareholders - TipRanks

Daxor (DXR) Secures FDA Clearance for Advanced Blood Volume Anal - GuruFocus

Daxor Corporation CEO And President Michael Feldschuh Provides Corporate Update In Letter To Shareholders - TradingView

7-pound blood volume analyzer wins FDA clearance, gains hospital users - Stock Titan

Daxor Corporation Reports 2025 Fiscal Year Results: Operating Revenue Up 45%, Net Asset Value Rises to $9.07 Per Share - marketscreener.com

Daxor Corporation Reports 2025 Fiscal Year Results: - GlobeNewswire

DXR Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

FDA‑cleared BVA boosts momentum; Daxor (NASDAQ: DXR) posts NAV $9.07 and $46M operating valuation - Stock Titan

Daxor Corporation Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Short Interest in Daxor Corporation (NASDAQ:DXR) Decreases By 44.0% - MarketBeat

Daxor Corporation (DXR) Competitors - Meyka

Daxor (NASDAQ:DXR) vs. Addus HomeCare (NASDAQ:ADUS) Financial Survey - Defense World

EBIT per share of Daxor Corporation – NASDAQ:DXR - TradingView

Daxor (NYSEAMERICAN:DXR) Share Price Crosses Below Two Hundred Day Moving AverageTime to Sell? - MarketBeat

Daxor continues strategic expansion, opens new BVA program in Tennessee - TipRanks

Daxor (DXR) Expands BVA Program to Southern Middle Tennessee - GuruFocus

Daxor Scales Outpatient Presence; Launches BVA Diagnostic Program in Tennessee - The Manila Times

Tennessee clinic adopts 24-hour, 98% accurate blood-volume test - Stock Titan

Gainers Report: Will LightPath Technologies Inc benefit from government policy2025 Key Lessons & Real-Time Stock Price Movement Reports - baoquankhu1.vn

Daxor (NYSEAMERICAN:DXR) Stock Crosses Below Two Hundred Day Moving AverageTime to Sell? - MarketBeat

Is Daxor Corporation stock a safe haven assetWeekly Profit Summary & Stock Portfolio Risk Control - mfd.ru

Can Daxor Corporation stock double in next 5 yearsTrade Risk Report & Fast Entry and Exit Trade Plans - mfd.ru

Daxor to shift regulatory reporting from Investment Company Act By Investing.com - Investing.com South Africa

Winners Losers: Is Daxor Corporation a turnaround storyWeekly Earnings Recap & Reliable Price Breakout Alerts - baoquankhu1.vn

Daxor Corp reaffirms focus on blood volume analysis technology - marketscreener.com

Daxor Corp Reaffirms Focus On Blood Volume Analysis Technology - TradingView

Daxor to transition to Securities Exchange Act of 1934 reporting company - TipRanks

Daxor Corporation Announces Transition To Securities Exchange Act of 1934 Reporting Company, Reaffirming Focus on Core Blood Volume Analysis and Diagnostic Business - The Manila Times

Daxor Corporation Announces Transition To Securities - GlobeNewswire

Daxor (NYSEAMERICAN:DXR) Stock Passes Below 200 Day Moving AverageTime to Sell? - MarketBeat

Trading the Move, Not the Narrative: (DXR) Edition - Stock Traders Daily

Daxor (NASDAQ:DXR) Stock Price Up 0.6%Time to Buy? - MarketBeat

Contrasting Daxor (NASDAQ:DXR) and Quest Diagnostics (NYSE:DGX) - Defense World

Aug Swings: Should I invest in Daxor Corporation before earningsPortfolio Profit Report & Safe Entry Point Alerts - baoquankhu1.vn

Daxor Corporation Azioni (DXR) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a DXR